Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 14;10(6):e180.
doi: 10.1192/bjo.2024.739.

Measuring clinical outcomes in adult ADHD clinics: psychometrics of a new scale, the adult ADHD Clinical Outcome Scale

Dimitrios Adamis  1 , Jasmin Singh  2 , Iulian Coada  2 , Margo Wrigley  3 , Blánaid Gavin  4 , Fiona McNicholas  5
Affiliations

Measuring clinical outcomes in adult ADHD clinics: psychometrics of a new scale, the adult ADHD Clinical Outcome Scale

Dimitrios Adamis et al. BJPsych Open. .

Abstract

Background: Adult attention-deficit hyperactivity disorder (ADHD) clinics are in their infancy in Ireland and internationally. There is an urgent need for clinical evaluation of these services. Until now, clinical outcomes have relied mainly on functional scales and/or quality of life. However, adult ADHD is a longstanding disorder with many comorbidities. Although medication for ADHD symptoms can have immediate effects, co-occurring problems may take considerably longer to remediate.

Aims: To present the psychometrics of a short outcome measure of key clinical areas including symptoms.

Method: The ADHD Clinical Outcome Scale (ACOS), developed by the authors, is a clinician-rated scale and was administered in consecutive adults attending an ADHD clinic. A modified version was completed by the participant. A second clinician independently administered the scale in a subsample. ACOS consists of 15 items rated on a Likert scale. Two self-report scales, the Adult ADHD Quality of Life Questionnaire (AAQoL) and Weiss Functional Impairment Rating Scale (WFIRS), were also administered.

Results: The mean age of 148 participants was 30.1 years (s.d. = 9.71), and 81 were female (54.7%). The correlation for interrater reliability was r = 0.868, and that between the participant and clinician versions was r = 0.663. The intraclass correlation coefficient for the internal consistency was 0.829, and the correlations for concurrent validity with total AAQoL and WFIRS scores were r = -0.573 and r = 0.477, respectively. Factor analysis revealed four factors: (a) attentional/organisational problems; (b) hyperactivity/impulsivity; (c) comorbidities; and (d) alcohol/drug use, self-harm and tension in relationships.

Conclusions: The psychometrics of the ACOS are promising, and the inclusion of typically co-occurring clinical domains makes it suitable for use as a clinician-rated outcome measure in every contact with patients attending adult ADHD clinics.

Keywords: ADHD Clinical Outcome Scale; Attention-deficit hyperactivity disorder; adults; psychometrics; routine clinical outcome monitoring.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Adamis D, Flynn C, Wrigley M, Gavin B, McNicholas F. ADHD in adults: a systematic review and meta-analysis of prevalence studies in outpatient psychiatric clinics. J Atten Disord 2022; 26(12): 1523–34. - PubMed
    1. Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Curr Med Res Opin 2013; 29(9): 1093–104. - PubMed
    1. Biederman J, DiSalvo M, Woodworth KY, Fried R, Uchida M, Biederman I, et al. Toward operationalizing deficient emotional self-regulation in newly referred adults with ADHD: a receiver operator characteristic curve analysis. Eur Psychiatry 2020; 63(1): e21. - PMC - PubMed
    1. Yadav SK, Bhat AA, Hashem S, Nisar S, Kamal M, Syed N, et al. Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder. Transl Psychiatry 2021; 11(1): 349. - PMC - PubMed
    1. Weiss MD. A paradigm for targeting functional impairment as an outcome in attention-deficit/hyperactivity disorder. Brain Sci 2022; 12(8): 1014. - PMC - PubMed

LinkOut - more resources